Risk-based means protecting what matters most
In clinical research, risk-based approaches are everywhere: they appear in protocols, monitoring plans, and quality systems. But there is a growing misunderstanding. Many organizations treat risk-based as a justification to reduce activities: fewer checks, lighter processes, less on-site monitoring. The goal is often simple: cut time and cost. Technically and regulatorily, this interpretation is wrong.…
How Risk-Based thinking drives digital trials
In recent years, clinical research has embraced a new vocabulary: decentralized, remote, hybrid, digitalized, connected. Terms that once belonged to the future now define our daily operations. With hybrid models (combining onsite visits with remote data collection) and the growing adoption of connected devices, ePRO platforms, study portals, and workflow management systems, clinical trials have…
When compliance isn’t enough: when is a clinical study truly safe?
Many clinical studies begin with a reassuring sense of security: the protocol is approved, the documentation is complete, regulatory requirements are met. Yet anyone who actually works in clinical research knows this: initial compliance is not the same as safety. The real question is not whether a study is compliant today, it is what happens…
